Implicity Raises $40M Growth Equity for AI Cardiac Monitoring

Implicity announced $40M in Growth Equity financing on September 9, 2026. Implicity raised a $40 million growth equity round led by IRIS, alongside Five Arrows, to support its growth in the US and further AI investment.

Round details

The financing includes backing from IRIS, Five Arrows. The company did not publish a valuation with the announcement.

Round: Growth Equity
Capital announced: $40M
Headquarters: Cambridge, MA and Paris, France

How the company plans to use the capital

Implicity said the round will fund commercial hiring in the US and development of US-specific features. It will also support continued investment in its AI and innovation roadmap, including the next generation of heart failure prediction algorithms.

Why this matters for GTM teams

IRIS led the round with Five Arrows participating. Implicity said it serves more than 250 medical centers and monitors more than 120,000 patients daily across the US, France and Germany.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: Implicity growth equity announcement.